EPAS1 and von Hippel-Lindau disease: The most well-known syndrome to associate erythrocytosis and tumorigenesis is von Hippel Lindau disease, but mutations in PHD1 and HIF2a (EPAS1) are also implicated in tumorigenesis [8, 11].